New HIV Vaccine Launches in the USA

Sales of the new HIV vaccine, Yeztugo, have started in the USA, promising up to 99% protection during unprotected sexual contact. This drug has undergone all necessary clinical trials and is considered safe and effective. To maintain immunity, two injections per year are recommended, making it convenient and easy to use. This innovation represents a significant step forward in the fight against the virus - it could completely change the approach to HIV prevention and significantly reduce infection rates.